Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues
Summary
The RNAscope HiPlex Assay enables researchers to gain greater insights into cellular mechanisms and functions by combining a simplistic workflow with the capability of simultaneously detecting up to twelve RNA targets. Comprehensive spatial studies require tools that permit higher multiplexing capabilities with minimal time, simple processing, and quality performance, while conserving precious samples. Jacob Swanson at the Hospital for Special Surgery in New York City, NY, commented, "The RNAscope HiPlex Assay allows a researcher to add histological context to scRNAseq data, which is important for fully understanding the biology of distinct cell populations. Being able to stain a single section of tissue with up to twelve mRNA probes makes the RNAscope HiPlex Assay a powerful tool for distinguishing cell types in situ. Kim Kelderman, President of Bio-Technes Diagnostics and Genomics Segment, commented, "We are pleased to expand our in situ RNA tissue analysis leadership position with the release of the RNAscope HiPlex Assay.
Classifications
AskAI Classifications
LabelsLinked Companies
